Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Method and apparatus for the prevention of a service degradation attack
Communication terminal device, and recording medium
Mesa-shaped piezoelectric resonator element
Three-dimensional holographic display using active shutter
Conductor for transmitting electrical power
Focus information generating device and focus information generating method
Methods and systems for providing a business repository
  Randomly Featured Patents
Circuit breaker for protecting motor
Press arm for screen printing equipment
Supporting different instruction set architectures during run time
Antihypertensive 4-aminoquinolines
Beverage bottle
Image processing method
Plasma reactor with overhead RF source power electrode with low loss, low arcing tendency and low contamination
Expandable fish hook
Motion estimator and a motion estimation method
Catheter device for performing a cholangiogram during a laparoscopy surgery